Streetbeat News

Stock Prices

WBA

Walgreens Boots Alliance (NASDAQ:WBA) has received mixed analyst ratings in the last quarter, with 9 indifferent, 1 somewhat bullish, and 1 somewhat bearish. The average price target is $33.91, implying an upside from the current price of $29.22. However, this average has decreased by 16.62% from the previous average price target of $40.67.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 7:00 pm

BTCUSD

Bitcoin's price has decreased by 3.49% over the past 24 hours to $30,164.00, contrary to its performance over the past week where it experienced an up-trend of 2.0%. Bitcoin's trading volume has climbed 64.0% over the past week and the circulating supply of the coin has increased 0.1% to 19.43 million, which makes up an estimated 92.52% of its max supply of 21.00 million. The current market cap ranking for BTC is #1 at $586.36 billion.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 7:00 pm

THRX

Theseus Pharmaceuticals Inc (NASDAQ:THRX) shares plummeted after the company announced discontinuation of enrollment in a phase 1/2 study and termination of the development of THE-630 for gastrointestinal stromal tumors due to dose-limiting toxicities. Analysts from Cantor Fitzgerald, Needham, Wedbush, and HC Wainwright have cut their price targets but remain optimistic about the company's platform. The company is considering developing low-dose THE-630 for KIT-associated mast cell-driven inflammatory indications.

Portfolio Pulse from Vandana Singh

July 14, 2023 | 6:59 pm

VITL

Needham analyst Matt McGinley reiterated a Hold rating on Vital Farms Inc (VITL), predicting single-digit volume growth due to bird flu induced supply shortage. The analyst estimates Q2 sales growth of 27% y/y to $105 million, driven by a combination of price and volume gains. However, concerns regarding volume growth have sent the stock down by over 25% since early May.

Portfolio Pulse from Shivani Kumaresan

July 14, 2023 | 6:57 pm

ACAD

Acadia Pharmaceuticals has expanded its licensing agreement for trofinetide with Neuren Pharmaceuticals, acquiring ex-North American rights to the drug. The company expects Q2 sales of $21-$23 million for Daybue and $140-$144 million for Nuplazid. JMP Securities and HC Wainwright have increased their price targets for Acadia, while Needham maintains a Hold rating. The successful launch of Daybue and the acquisition of global rights to trofinetide are seen as strategic moves.

Portfolio Pulse from Vandana Singh

July 14, 2023 | 6:47 pm

BIDU

A significant bullish stance on Baidu (NASDAQ:BIDU) has been observed through unusual options activity. The sentiment among these big-money traders is split between 58% bullish and 41% bearish. The whales have been targeting a price range from $120.0 to $170.0 for Baidu over the last 3 months. Morgan Stanley upgraded its action to Overweight with a price target of $190, while B of A Securities maintained their Buy rating with a price target of $228.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:47 pm

OXY

A significant bearish stance has been taken on Occidental Petroleum (NYSE:OXY) by a large investor, as observed in the unusual options activity. The sentiment among these big-money traders is split between 47% bullish and 52% bearish. The whales have been targeting a price range from $20.0 to $75.0 for Occidental Petroleum over the last 3 months. Citigroup and Stephens & Co. have downgraded their actions on OXY with price targets of $62 and $72 respectively.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:47 pm

DE

A significant bearish stance has been taken on Deere (NYSE:DE) by a large investor, as observed in the unusual options activity. The sentiment among these big-money traders is split between 27% bullish and 72% bearish. The whales have been targeting a price range from $300.0 to $460.0 for Deere over the last 3 months. Canaccord Genuity has downgraded its action to Buy with a price target of $530.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:47 pm

WFC

Wells Fargo & Co (NYSE:WFC) reported upbeat Q2 earnings, beating estimates on both top and bottom lines. The bank posted a net income of $4.9 billion, up from $3.1 billion in the same quarter last year, largely due to higher interest rates. It also repurchased 100.2 million shares during the quarter, totaling a $4 billion buyback. The bank's stock is trading 0.55% lower at the time of writing. For an investor to yield $500 per month from the stock, they would need to hold approximately $218,181.81 in the stock, or 5,019 shares.

Portfolio Pulse from AJ Fabino

July 14, 2023 | 6:43 pm

ACB

CRON

GRWG

SNDL

TLRY

Cannabis stocks are trading lower due to reported roadblocks over the SAFE Banking Act. This includes Aurora Cannabis (ACB), Cronos Group (CRON), GrowGeneration Corp (GRWG), Sundial Growers (SNDL), and Tilray (TLRY).

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:43 pm